Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship. He is a practicing senior clinical neuropsychologist at the Royal Children's Hospital and an Honorary Principal Research Fellow in the Department of Paediatrics, University of Melbourne.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship....
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship. He is a practicing senior clinical neuropsychologist at the Royal Children's Hospital and an Honorary Principal Research Fellow in the Department of Paediatrics, University of Melbourne.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Top Publications
Zendarski, N, Galligan, R, Coghill, D, Payne, JM, De Luca, CR, Mulraney, M.
The Associations between Child Irritability, Parental Distress, Parental Irritability and Family Functioning in Children Accessing Mental Health Services.
Journal of Child and Family Studies
32(1)
:
288 -300
2023
view publication
de Blank, PMK, Gross, AM, Akshintala, S, Blakeley, JO, Bollag, G, Cannon, A, Dombi, E, Fangusaro, J, Gelb, BD, Hargrave, D, et al.
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus..
Neuro Oncol
24(11)
:
1845 -1856
2022
view publication
Rance, G, Maier, A, Zanin, J, Haebich, KM, North, KN, Orsini, F, Dabscheck, G, Delatycki, MB, Payne, JM.
A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1..
Neurol Sci
43(9)
:
5637 -5641
2022
view publication
Mulraney, M, Sciberras, E, Payne, JM, De Luca, C, Mills, J, Tennant, M, Coghill, D.
Collaborative and Proactive Solutions compared with usual care to treat irritability in children and adolescents: a pilot randomized controlled trial.
Clinical Psychologist
26(2)
:
231 -239
2022
view publication
Haebich, KM, Dao, DP, Pride, NA, Barton, B, Walsh, KS, Maier, A, Chisholm, AK, Darke, H, Catroppa, C, Malarbi, S, et al.
The mediating role of ADHD symptoms between executive function and social skills in children with neurofibromatosis type 1..
Child Neuropsychol
28(3)
:
318 -336
2022
view publication